Clinical trial

Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb®) (PGT)

NCT01133912

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-03-01

PhasePHASE1

Study timeline

Study start (unknown)2009-03-01Date precision: month

Registry last updated2012-01-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

paclitaxel, gemcitabine, lapatinibDRUG

Sponsors & collaborators

Jungsil Rolead sponsor

GlaxoSmithKlinecollaborator

HK inno.N Corporationcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01133912 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.